Northway Biotech is an end-to-end contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of protein-based biologics and gene therapies. With continuous expansion, 20+ years of technical expertise and a vertically integrated service model, we are uniquely positioned to rapidly execute multiple projects across development stages, from preclinical to commercial, while ensuring full regulatory compliance.
Our 3 state-of-the-art facilities in the EU (Vilnius, Lithuania) and US (Waltham, MA) include comprehensive capabilities for cell line development, process development, analytical development, as well as cGMP manufacturing of drug substances and drug products. Whether mammalian cell culture or microbial processing is optimal for your product's development, our cGMP facilities are equipped with multiple production units to support the development and manufacturing of your drug substance and aseptic drug product.
As Nipah Virus Outbreaks in India Re-emerge, ExpreS2ion Selects Northway Biotech as Manufacturing Partner for Vaccine Program
Read MoreNorthway Biotech joins a Lithuanian Consortium for Engagement with MIT – aiming to jointly strengthen life sciences sector in Lithuania
Read MoreOctober 6-8, 2026
Milan, Italy
Booth TBA
May 11-15, 2026
Boston, MA
Booth TBA
October 27-30, 2026
Hamburg, Germany
Booth TBA
September 22-25, 2026
Boston, MA
Booth TBA
June 22-25, 2026
San Diego, CA
Booth TBA
May 4-5, 2026
Basel, Switzerland
Booth NA
November 9-11, 2026
Cologne, Germany
Booth TBA
October 13-15, 2026
Basel, Switzerland
Booth NA
